Noncanonical calcium-independent TRPM4 activation governs intestinal fluid homeostasis
- Nat Commun. 2026 Jan 8;17(1):1253. doi: 10.1038/s41467-025-68014-7.
- 1. State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Jiangsu, China.
- 2. Jiangsu Provincial Key Laboratory for TCM Evaluation and Translational Development, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China.
- 3. Department of Molecular Biosciences, Northwestern University, Evanston, IL, USA.
- 4. Van Andel Institute, Grand Rapids, MI, USA.
- 5. Department of Molecular Biosciences, Northwestern University, Evanston, IL, USA. [email protected].
- 6. Department of Pharmacology, Northwestern University; Feinberg School of Medicine, Chicago, IL, USA. [email protected].
- 7. Chemistry of Life Processes Institute, Northwestern University, Evanston, IL, USA. [email protected].
- 8. Department of Molecular Biosciences, Northwestern University, Evanston, IL, USA. [email protected].
- 9. Department of Pharmacology, Northwestern University; Feinberg School of Medicine, Chicago, IL, USA. [email protected].
- 10. Chemistry of Life Processes Institute, Northwestern University, Evanston, IL, USA. [email protected].
- 11. State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Jiangsu, China. [email protected].
- 12. Jiangsu Provincial Key Laboratory for TCM Evaluation and Translational Development, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China. [email protected].
- # Contributed equally.
Imbalance in intestinal fluid homeostasis leads to nutrient malabsorption, intestinal tissue destruction, and systemic inflammation. Transient receptor potential melastatin 4 (TRPM4) is a calcium-activated, non-selective monovalent cation channel converting chemical signals (CA2+) into electrical signals (membrane depolarization). Here, we show the TRPM4 channel as a direct target of bisacodyl (BIC), a widely used clinical drug for chronic constipation management, and its active metabolite, deacetyl bisacodyl (DAB). DAB-induced laxative effects are abolished in global and intestinal epithelium-specific TRPM4-knockout mice, establishing the essential role of TRPM4 in intestinal fluid regulation. Furthermore, our structural work reveals DAB bound to an uncharacterized pocket, marking it as a non-Ca2+ TRPM4 agonist and unveiling a noncanonical CA2+-independent activation mechanism. Additionally, we delineate a signaling axis, TRPM4 → VGCC/NCX → ANO1, that governs ion homeostasis in the epithelium. Together, these findings establish TRPM4 as a key regulator of intestinal fluid balance and reveal its noncanonical calcium-independent activation as a therapeutic strategy for constipation.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Infection
-
-
-
-
Research Areas: Cancer
-
target: TRP ChannelResearch Areas: Neurological Disease
-
target: Na+/Ca2+ ExchangerResearch Areas: Cardiovascular Disease
-
target: Chloride Channel
-
target: Chloride Channel
-
target: TRP ChannelResearch Areas: Cardiovascular Disease
-
-
target: Biochemical Assay ReagentsResearch Areas: Others